(Q44007864)

28 November 2017

title

Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells (English)

1 reference

28 November 2017

1 reference

1 reference

Zhuo Wang

1 reference

28 November 2017

Satoru Kyo

1 reference

28 November 2017

Yoshiko Maida

1 reference

28 November 2017

Masahiro Takakura

1 reference

28 November 2017

Masaaki Tanaka

1 reference

28 November 2017

Noriyuki Yatabe

1 reference

28 November 2017

Taro Kanaya

1 reference

28 November 2017

Mitsuhiro Nakamura

1 reference

28 November 2017

Koji Koike

1 reference

28 November 2017

Koji Hisamoto

1 reference

28 November 2017

Masahide Ohmichi

1 reference

28 November 2017

Masaki Inoue

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

3517-3524

1 reference

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Extension of life-span by introduction of telomerase into normal human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Rapid activation of MAP kinase by estrogen in the bone cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Inhibition of telomerase limits the growth of human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Telomerase, Cell Immortality, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

The effect of anti-oestrogens on cell growth and progesterone receptor concentration in human endometrial cancer cells (Ishikawa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Peptide antagonists of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Breast cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

A survey of telomerase activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone: evidence for the involvement of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

The human estrogen receptor has two independent nonacidic transcriptional activation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

Estrogen hits the surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

7 January 2021

Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

7 January 2021

Update on raloxifene to prevent endometrial-breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

7 January 2021

Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

7 January 2021

Tamoxifen and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

7 January 2021

Alterations in steroid hormone receptors in the tamoxifen-treated endometrium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

7 January 2021

The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

7 January 2021

Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205463

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205463

1 reference

28 November 2017

1 reference